BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8356943)

  • 1. Diagnosis of hereditary spherocytosis with dual-angle differential light scattering.
    Gilsanz F; Ricard MP; Millan I
    Am J Clin Pathol; 1993 Aug; 100(2):119-22. PubMed ID: 8356943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in laboratory diagnosis of hereditary spherocytosis.
    Farias MG
    Clin Chem Lab Med; 2017 Jun; 55(7):944-948. PubMed ID: 27837594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of mean sphered cell volume and mean reticulocyte volume for the diagnosis of hereditary spherocytosis.
    Arora RD; Dass J; Maydeo S; Arya V; Kotwal J; Bhargava M
    Hematology; 2018 Aug; 23(7):413-416. PubMed ID: 29338606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red blood cell aquaporin-1 expression is decreased in hereditary spherocytosis.
    Crisp RL; Maltaneri RE; Vittori DC; Solari L; Gammella D; Schvartzman G; García E; Rapetti MC; Donato H; Nesse A
    Ann Hematol; 2016 Oct; 95(10):1595-601. PubMed ID: 27465156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mean reticulocyte volume: a specific parameter to screen for hereditary spherocytosis.
    Xu Y; Yang W; Liao L; Deng Z; Qiu Y; Chen W; Lin F
    Eur J Haematol; 2016 Feb; 96(2):170-4. PubMed ID: 25868528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal differences in membrane loss lead to distinct reticulocyte features in hereditary spherocytosis and in immune hemolytic anemia.
    Da Costa L; Mohandas N; Sorette M; Grange MJ; Tchernia G; Cynober T
    Blood; 2001 Nov; 98(10):2894-9. PubMed ID: 11698268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percentage of hyperdense cells: Automated parameter to hereditary spherocytosis screening.
    Farias MG; Freitas PA
    Clin Biochem; 2015 Dec; 48(18):1341-3. PubMed ID: 26210847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison study of the eosin-5'-maleimide binding test, flow cytometric osmotic fragility test, and cryohemolysis test in the diagnosis of hereditary spherocytosis.
    Park SH; Park CJ; Lee BR; Cho YU; Jang S; Kim N; Koh KN; Im HJ; Seo JJ; Park ES; Lee JW; Yoo KH; Jung HL
    Am J Clin Pathol; 2014 Oct; 142(4):474-84. PubMed ID: 25239414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of splenectomy in hereditary spherocytosis by dual angle laser light cytometry.
    Ricard MP; Gilsanz F
    Clin Lab Haematol; 1996 Dec; 18(4):249-51. PubMed ID: 9054697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of eosin-5-maleimide flow cytometric test in diagnosis of hereditary spherocytosis.
    Kar R; Mishra P; Pati HP
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 2):8-16. PubMed ID: 18782334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric osmotic fragility test and eosin-5'-maleimide dye-binding tests are better than conventional osmotic fragility tests for the diagnosis of hereditary spherocytosis.
    Arora RD; Dass J; Maydeo S; Arya V; Radhakrishnan N; Sachdeva A; Kotwal J; Bhargava M
    Int J Lab Hematol; 2018 Jun; 40(3):335-342. PubMed ID: 29573337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does preincubation of the red blood cells contribute to the capability of the osmotic fragility test to detect very mild forms of hereditary spherocytosis?
    Godal HC; Gjønnes G; Ruyter R
    Scand J Haematol; 1982 Jul; 29(1):89-93. PubMed ID: 7123155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormality in a specific protein of the erythrocyte membrane in hereditary spherocytosis.
    Hayashi S; Koomoto R; Yano A; Ishigami S; Tsujino G
    Biochem Biophys Res Commun; 1974 Apr; 57(4):1038-44. PubMed ID: 4830746
    [No Abstract]   [Full Text] [Related]  

  • 14. Elevated levels of redox regulators, membrane-bound globin chains, and cytoskeletal protein fragments in hereditary spherocytosis erythrocyte proteome.
    Saha S; Ramanathan R; Basu A; Banerjee D; Chakrabarti A
    Eur J Haematol; 2011 Sep; 87(3):259-66. PubMed ID: 21575061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric osmotic fragility testing does reflect the clinical severity of hereditary spherocytosis.
    Shim YJ; Won DI
    Cytometry B Clin Cytom; 2014 Nov; 86(6):436-43. PubMed ID: 24243866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Flow-assisted differential diagnosis of hemolytic anemia with spherocytosis: a case report].
    Won DI
    Korean J Lab Med; 2010 Aug; 30(4):339-44. PubMed ID: 20805704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the severity of hereditary spherocytosis using routine haematological data obtained with dual angle laser scattering cytometry.
    Ricard MP; Gilsanz F
    Clin Lab Haematol; 1996 Jun; 18(2):75-8. PubMed ID: 9081777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementary markers for the clinical severity classification of hereditary spherocytosis in unsplenectomized patients.
    Rocha S; Costa E; Rocha-Pereira P; Ferreira F; Cleto E; Barbot J; Quintanilha A; Belo L; Santos-Silva A
    Blood Cells Mol Dis; 2011 Feb; 46(2):166-70. PubMed ID: 21138793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using the eosin-5-maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis.
    King MJ; Telfer P; MacKinnon H; Langabeer L; McMahon C; Darbyshire P; Dhermy D
    Cytometry B Clin Cytom; 2008 Jul; 74(4):244-50. PubMed ID: 18454487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic protocol for hereditary spherocytosis-2021 update.
    Wu Y; Liao L; Lin F
    J Clin Lab Anal; 2021 Dec; 35(12):e24034. PubMed ID: 34689357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.